Scott Monroe New Director of FDA’s Division of Reproductive and Urologic Products
Scott Monroe, MD, has accepted the position of director of the Division of Reproductive and Urologic Products (DRUP) at the US Food and Drug Administration.
Scott Monroe, MD, has accepted the position of director of the Division of Reproductive and Urologic Products (DRUP) at the US Food and Drug Administration. Monroe has been serving as the acting director for DRUP since June of 2006. He joined the FDA in 2000 as a medical officer in DRUP. Monroe was promoted to medical team leader in 2002, deputy division director in 2005, and acting division director in 2006.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
